Octreotide- mediated N-octyl-O, N-carboxymethyl chitosan micelles: Preparation, characterization and research as doxorubicin delivery vectors

Journal of China Pharmaceutical University

Volumn 42, Issue 2, 2011, Pages 124-130

  Zou, Ai Feng ^a   Huo, Mei Rong ^a   Zhou, Jian Ping ^a   Yin, Xiao Qiang ^a   Yao, Cheng Li ^a   Zhu, Qin Nü ^a   Zhang, Min ^b   Ren, Jin Shan ^b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b Jiangsu Institute of Materia Medica   (China)

Author keywords

Active targeted; Doxorubicin; In vitro release; Octreotide; Polymeric micelles

Indexed keywords

CHITOSAN DERIVATIVE; DOXORUBICIN; MACROGOL; N OCTYL O, N CARBOXYMETHYL CHITOSAN; OCTREOTIDE; UNCLASSIFIED DRUG; WATER;

ARTICLE; CANCER THERAPY; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DIALYSIS; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MICELLE; PH; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 79959789386     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ieva E, Trapani A, Cioffi N, et al. Analytical characterization of chitosan nanoparticles for peptide drug delivery applications[J]. Anal Bioanal Chem, 2009,393(1):207-215. (Pubitemid 50316506)
2. van der Lubben IM, Verhoef JC, Borchard G, et al. Chitosan and its derivatives in mucosal drug and vaccine delivery[J]. Eur J Pharm Sci, 2001,14(3):201-207. (Pubitemid 32884316)
3. Bhattarai N, Ramay HR, Chou SH, et al. Chitosan and lactic acid-grafted chitosan nanoparticles as carriers for prolonged drug delivery[J]. Int J Nanomed, 2006,1(2):181-187.
4. (Huo MR), (Zhou JP), (Zhang Y), (J China Pharm Univ), 2007,38(6):512-515.
5. Duran-Prado M, Saveanu A, Luque RM, et al. A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs[J]. J Clin Endocrinol Metab, 2010,95(5):2497-2502.
6. Morisco A, Accardo A, Gianolio E, et al. Micelles derivatized with octreotide as potential target-selective contrast agents in MRI[J]. J Peptide Sci, 2009,15(3):242-250.
7. Gehler B, Paulsen F, Oksuz M, et al. [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning[J]. Rad Oncol, 2009,4(1):56.
8. Limouris G, Chatziioannou A, Kontogeorgakos D, et al. Selective hepatic arterial infusion of In-111-DTPA-Phel-octreotide in neuroendocrine liver metastases[J]. Eur J Nucl Med Mol Imaging, 2008,35(10):1827-1837.
9. Moody TW, Fuselier J, Coy DH, et al. Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells[J]. Peptides, 2005,26(9):1560-1566.
10. Sun ML, Wei JM, Wang XW, et al. Paclitaxel-octreotide conjugates inhibit growth of human non-small cell lung cancer cells in vitro[J]. Exp Oncol, 2007,29(3):186-191.
11. Keller G, Schally AV, Nagy A, et al. Effective therapy of experimental human malignant melanomas with a targeted cytotoxic somatostatin analogue without induction of multi-drug resistance proteins[J]. Int J Oncol, 2006,28(6):1507-1513.
12. Huo M, Zhang Y. Zhou J, et al. Synthesis and characterization of low-toxic amphophilic chitosan derivatives and their application as micelle carrier for antitumor drug[J]. Int J Pharm, 2010,394(1/2):162-173.
13. Yang R, Shim WS, Cui FD, et al. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumo[J]. Int J Pharm, 2009,371(1/2):142-147.
14. Kim D, Gao ZG, Lee ES, et al. In vivo evaluation of doxorubicin-loaded polymeric micelles targeting folate receptors and early endosomal pH in drug-resistant ovarian cancer[J]. Mol Pharm, 2009,6(5):1353-1362.
15. Du JZ, Tang LY, Song WJ, et al. Evaluation of polymeric micelles from brush polymer with poly(epsilon-caprolactone)-b-poly(ethylene glycol) side chains as drug carrier[J]. Biomacromolecules, 2009,10(8):2169-2174.
16. Dong Y, Feng SS. Methoxy poly(ethylene glycol) -poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs[J]. Biomaterials, 2004,25(14):2843-2849. (Pubitemid 38201309)
17. Sahay G, Kim JO, Kabanov AV, et al. The exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agents[J]. Biomaterials, 2010,31(5):923-933.
18. Prabaharan M, Grailer JJ, Pilla S, et al. Amphiphilic multi-armblock copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery[J]. Biomaterials, 2009,30(29):5757-5766.
19. Kim JO, Kabanov AV, Bronich TK. Polymer micelles with crosslinked polyanion core for delivery of a cationic drug doxorubicin[J]. J Control Release, 2009,138(3):197-204.